Clinical trial
Galantamine for Cognitive Deficits in Schizophrenia
NCT00463879 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Galantamine for Cognitive Deficits in Schizophrenia
- Lead sponsor
- Yale University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 30, 2005
- Completion date
- September 30, 2007
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.